Technical Monday: Big Brother Biotechnology

Mish Schneider | December 9, 2024

One of the big themes we see emerging into 2025 is an expansion in Biotechnology. 

XBI is certainly a good ETF to look at. 

However, we have used the ETF IBB, our Big Brother in the Economic Economic Modern Family, …


Long Bonds TLT: Agony and Ecstasy

Mish Schneider | December 4, 2024

Today, the Chairman of the Federal Reserve, Jerome Powell spoke.

Some highlights

  • U.S. BUDGET IS ON AN UNSUSTAINABLE PATH; REVENUE AND SPENDING NEED TO BE BETTER ALIGNED
  • CENTRAL BANK CANNOT TAKE DEBT AND DEFICITS INTO ACCOUNT IN SETTING RATES; NEEDS

  • Turnaround Tuesday: A Look at Emerging Markets

    Mish Schneider | December 3, 2024

    The DAX is a stock market index consisting of the 40 major German blue-chip companies trading on the Frankfurt Stock Exchange.  

    Here are the top five weighted sectors: 

    Sector Weightings 

    Industrials 24.51% 

    Financial Services 20.33% 

    Technology 18.47% 

    Consumer Cyclical 10.27% …


    Technical Monday: Novo-Nordisk, A Love Story

    Mish Schneider | December 2, 2024

    Novo Nordisk, the company behind Ozempic and Wegovy, is now Europe's largest company as global demand for its drugs have soared.  

    However, the Danish pharmaceutical began because of more personal reasons. 

    In the early 1920s, Nobel laureate August Krogh and …


    The Economic Modern Family Talks Turkey

    Mish Schneider | November 27, 2024

    While this is the last Daily of this week, I want to start with a quick rundown of the Economic Economic Modern Family. 

    As Friday is a ½ day and Black Friday, we can only guess that based on a …


    Turnaround Tuesday: Rivian

    Mish Schneider | November 26, 2024

    I have a few central themes for 2025. 

    One is the ‘vanity’ trade based on the diet drugs. News today was that Biden administration is looking to expand coverage for the drugs through Medicare. 

    That could be reversed by Trump …


    Technical Monday: A Fresh Look at the “Vanity” Trade

    Mish Schneider | November 25, 2024

    With such a great start to the holiday week, we could not help but gloat a little about the stocks I have mentioned related to the diet drugs, or what I call the “vanity” trade.

    IPAR (perfumes), ELF (cosmetics) ULTA …


    Economic Modern Family-Granny Did It! Retail Rallies

    Mish Schneider | November 24, 2024

    How long have we talked about the massive nearly 11-month price consolidation in our dear Granny Retail XRT? 

    What we waited for was a weekly close over 79.20, a level we have not seen since February 2022. 

    The Family, catching …


    Are Diet Drug Companies Over the Hump?

    Mish Schneider | November 20, 2024

    For hump Wednesday, I am asking the question on whether the two premier diet drug companies are finally over the hump and have stopped the bleed?

    Today I read this:

    WEIGHT-LOSS DRUG COVERAGE RISES AMONG LARGE US EMPLOYERS IN 2024: …


    Has Granny Retail Reversed or Ever Breakout?

    Mish Schneider | November 19, 2024

    For Turnaround Tuesday, let’s reexamine the ETF XRT, which we have tracked all year. 

    Since February 2024, XRT has been in a massive consolidation. 

    While the ETF recently looked poised for a breakout and a weekly close over $80, the …